|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||7.13 / 12.15|
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.
Non-invasive prenatal test that harnesses the power of massively parallel sequencing to screen for fetal chromosomal abnormalities
Is this small-cap biotech play the best way to profit from the growing worldwide demand for vaccines?
Jim Cramer says Opko Health has lost its mojo; but he's bullish on KBR for its cash stash.
Growth is not only about the occupant of the Oval Office, say Jim Cramer. This is a genuine bull market, and it's about how you invest.
BLL, OPK, ESRX, SKYW and DLA all were recently downgraded by TheStreet's Quant Ratings.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AEUA, APC, CBL, DFRG, EFII, ENR, EPAY, EXTR, HMTV, OCLR, PGEM, PODD, SFLY, TUP Downgrades: CVX, FNFV, OPK Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Insiders at these companies -- including Opko Health and Mirati Therapeutics -- have been scooping up shares of their own stock lately.
Stocks closed lower on the final trading day of 2016, but all three indices close the year with gains.
Stocks close out the day slightly down, but post gains for 2016.
Stocks moved mostly lower on the final day of trading of 2016, but all three indices are poised to close 2016 with gains.
Stocks were falling below the baseline as 2016 comes to a close.